Publication:

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study

 
dc.contributor.authorDe Corte, Thomas
dc.contributor.authorVerhaeghe, Jarne
dc.contributor.authorDhaese, Sofie
dc.contributor.authorVan Vooren, Sarah
dc.contributor.authorBoelens, Jerina
dc.contributor.authorG. Verstraete, Alain
dc.contributor.authorStove, Veronique
dc.contributor.authorOngenae, Femke
dc.contributor.authorDe Bus, Liesbet
dc.contributor.authorDepuydt, Pieter
dc.contributor.authorVan Hoecke, Sofie
dc.contributor.authorJ. De Waele, Jan
dc.contributor.imecauthorVerhaeghe, Jarne
dc.contributor.imecauthorOngenae, Femke
dc.contributor.imecauthorVan Hoecke, Sofie
dc.contributor.orcidimecVerhaeghe, Jarne::0000-0002-3322-150X
dc.contributor.orcidimecOngenae, Femke::0000-0003-2529-5477
dc.contributor.orcidimecVan Hoecke, Sofie::0000-0002-7865-6793
dc.date.accessioned2023-07-10T12:31:07Z
dc.date.available2023-05-15T20:01:35Z
dc.date.available2023-05-16T10:41:20Z
dc.date.available2023-07-10T12:31:07Z
dc.date.embargo2023-04-29
dc.date.issued2023
dc.identifier.doi10.1186/s13613-023-01129-6
dc.identifier.issn2110-5820
dc.identifier.pmidMEDLINE:37119362
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/41592
dc.publisherSPRINGER
dc.source.beginpageArt. 35
dc.source.endpagena
dc.source.issue1
dc.source.journalANNALS OF INTENSIVE CARE
dc.source.numberofpages17
dc.source.volume13
dc.subject.keywordsCARE-UNIT PATIENTS
dc.title

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study

dc.typeJournal article
dspace.entity.typePublication
Files

Original bundle

Name:
DS626.pdf
Size:
4.81 MB
Format:
Adobe Portable Document Format
Description:
Published version
Publication available in collections: